Skip to content
★ Sign in to follow
MA

Michael Aronstein

AngioGenex, Inc.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€174k
▼ Sales (0 ops.)
—

Latest filing published 04 Feb 2019 for AngioGenex, Inc., €174k.

Filing timeline

BuySale
Michael Aronstein

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Michael Aronstein: trading record in brief

One trade, one date: on 4 February 2019, Michael Aronstein disclosed an open-market purchase of €174k in AngioGenex, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Michael Aronstein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    DirectorExecutivesAngioGenex, Inc.
    200,000 USD19SEC
    1,000,000 shares@ US$0.20100.0% of flowCOMMON STOCKSEC:0001469709-19-000006:0
    Canonical exit: 15 Apr 2019 (T+90)

1 of 1 declaration